Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
30.02 USD | +13.24% | +0.99% | -21.43% |
05-07 | Transcript : Pacira BioSciences, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
05-07 | Earnings Flash (PCRX) PACIRA BIOSCIENCES Reports Q1 Revenue $167.1M, vs. Street Est of $165.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.43% | 1.23B | |
+33.43% | 700B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+15.87% | 236B | |
+6.79% | 202B | |
-9.04% | 197B | |
+4.26% | 161B | |
-3.54% | 157B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- RBC Cuts Price Target on Pacira BioSciences to $45 From $53, Keeps Outperform Rating